EGFR signaling, frequently upregulated in CRC, activates downstream pathways such as RAS/RAF/MEK/ERK and PI3K/AKT, which drive cell proliferation, migration, and resistance to apoptosis [5, 6]. The gene discussed is EGFR; the disease is colorectal carcinoma.